Guardant Health, Inc. (NASDAQ:GH) Q4 2023 Earnings Call Transcript
Operator: Good afternoon. Thank you for attending the Guardant Health Q4 2024 Earnings Call. My name is Victoria and I'll be your moderator today.
Guardant Health Inc. (GH)
Market is closed
Sector: Services-Medical Laboratories
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | ARK Investment Management Catherine D. Wood | 361,166 | $7,450,846 | -18% | 0.05% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $17.82 | 2,187 | Officer | 12,722 | 2024-03-18 | Filing | |
| $32.78 | 750 | Officer | 5,193 | 2023-06-09 | Filing | |
| $32.68 | 2,231 | Officer | 4,443 | 2023-06-09 | Filing | |
| $26.15 | 8,600 | Officer, Director | 2,049,238 | 2023-03-15 | Filing | |
| $26.33 | 84,452 | Officer, Director | 2,040,638 | 2023-03-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $19.05 | 100 | Director | 4,521 | 2024-03-04 | Filing | |
| $26.34 | 100 | Director | 4,422 | 2023-12-04 | Filing | |
| $26.37 | 5,800 | Officer | 5,926 | 2023-12-01 | Filing | |
| $32.59 | 2,125 | Officer | 7,813 | 2023-09-12 | Filing | |
| $35.01 | 100 | Director | 4,323 | 2023-09-05 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 11,130,654 | $301,084,191 | 0% | |
| 2. | 10,831,716 | $292,997,911 | 0% | |
| 3. | 6,178,812 | $167,136,864 | 0.13% | |
| 4. | 5,251,349 | $142,049,000 | 0.01% | |
| 5. | 4,001,803 | $108,248,771 | 0.02% |
News See All
Guardant Health, Inc. (NASDAQ:GH) Q3 2023 Earnings Call Transcript
Operator: Hello, everyone, and welcome to the Guardant Health Q3 2023 Earnings Call. My name is Thrisha, and I'll be your operator today.
11 Best Immunotherapy Stocks To Buy Now
In this article, we discuss 11 of the best immunotherapy stocks to buy now.
14 Best Cancer Stocks To Buy Now
The global oncology landscape continues to evolve, with ongoing efforts to discover, develop, and provide innovative treatments aimed at improving outcomes for a growing number of patients.
Guardant Health, Inc. (NASDAQ:GH) Q2 2023 Earnings Call Transcript
Operator: Hello, everyone, and welcome to the Guardant Health Second Quarter 2023 Earnings Call. My name is Emily, and I'll be coordinating your call today. [Operator Instructions].
Guardant Health (GH) Reports Solid Q2 Results
Aristotle Atlantic Partners, an investment management firm, released its second quarter 2023 investor letter, a copy of which can be downloaded here.
Viking Global's Performance, AUM, and Long-Term Stock Picks
In this article, we discuss Viking Global's performance, AUM, and 10 long-term stock picks.
Guardant Health, Inc. (NASDAQ:GH) Q1 2023 Earnings Call Transcript
Operator: Hello, and welcome to the Guardant Health First Quarter 2023 Financial Results Call. My name is Lauren and I will be coordinating your call today.
Guardant Health (GH) Fell on Eclipse Trial Release
Aristotle Atlantic Partners, LLC, an investment advisor, released its “Focus Growth Strategy” fourth quarter 2022 investor letter. A copy of the same can be downloaded here.
Hedge Fund and Insider Trading News: Elliott Management, Accendo Capital, Haidar Capital Management, Odey Asset Management, Guardant Health Inc (GH), New Mountain Finance Corp. (NMFC), and More
Elliott Investment Management on Thursday raised its stake in gold-focused streaming and royalty firm Triple Flag Precious Metals Corp to 67% from 64.7%.
Billionaire Hedge Funds
